Where does Azitra Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Azitra Inc. ranks #39,000 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Azitra Inc. hold?

Azitra Inc. holds 6 US utility patents granted between 2020 and 2025, spanning 6 technology areas.

What is Azitra Inc.'s Innovation Score?

Azitra Inc. has an Innovation Score of 31.2 out of 100 (37th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Azitra Inc. focus on?

Azitra Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 5 patents, ranking #3,434 of 6,058 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Azitra Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Azitra Inc..

What does claim depth mean for Azitra Inc.'s patents?

Azitra Inc.'s patents average 9.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Azitra Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Azitra Inc.

USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Azitra ranks #39,000 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 6 technology areas.

#39,000
of 49,997 US assignees by volume: 37th percentile
by Innovation Score (31.2/100): 9.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R39000 · US Corporation #39,000 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #39,000/49,997
PHOTO-FINISH Aarke AB
CPC-NARROW A61P · 6 areas
INNOV-THIN 31.2/100
CLAIMS-PAR 9.7 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Aarke AB (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Azitra’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (21%) Velocity 10.0 pts (32%) Breadth 8.7 pts (28%) Claim depth 5.8 pts (19%)

Qualcomm Incorporated · highest

85
Azitra · this assignee

31
3D Lighting… · lowest

7

What this shows Azitra's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Azitra?

Each dot is one of Azitra’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Azitra’s own 9.7 claims/patent is at or below the 14.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Azitra vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Azitra's grants concentrate

Azitra Inc. is a focused PatentsView assignee: 6 CPC subclasses with 83.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2020. By volume, Azitra sits between Axolabs GMBH and Acacia Technology, Inc..

Azitra's three-year grant acceleration

Azitra Inc. shows 3 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Axolabs

6
Axon Vibe

6
AXT

6
Axxana (Israel)

6
Aarke AB

6
Abela Pharmaceuti…

6
Abon Biopharm (Ha…

6
Acacia Technology

6
Azitra ◀

6

What this shows Azitra holds 6 patents at rank #38,756, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Azitra

By rank, the assignees closest to #38,756 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Azitra's primary technology class.

Azitra's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Azitra Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	16.7%
2021	1	16.7%
2023	2	33.3%
2024	1	16.7%
2025partial year	1	16.7%

Which technologies does Azitra Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

C07K - Peptides 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C12Y - Enzymes 1

C12R - Indexing Scheme Associated With Subclasses C12c - C12q, Relating TO Microorganisms 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Azitra Inc.'s patent record in context - here's where to go next.

Azitra Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 83.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #39,000 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Azitra Inc. against Axolabs GMBH, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.